Winslow Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Winslow Capital Management's AMGN Position: Q2 2020 in Review
Winslow Capital Management sold out of Amgen (AMGN) in Q2 2020, closing a stake of 1,491,285 shares — an estimated $302M sold.
Winslow Capital Management first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $645M in Q4 2013. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.
- Winslow Capital Management reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
- Winslow Capital Management sold 1,491,285 Amgen shares in Q2 2020, an estimated $302M.
- Winslow Capital Management first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
- Winslow Capital Management's Amgen position peaked at $645M in Q4 2013.
- 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.
Based on Winslow Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.